Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice
Open accessAbstract
Cerebral inflammation involves molecular cascades contributing to progressive damage after traumatic brain injury (TBI). The chemokine CC ligand-2 (CCL2) (formerly monocyte chemoattractant protein-1, MCP-1) is implicated in macrophage recruitment into damaged parenchyma after TBI. This study analyzed the presence of CCL2 in human TBI, and further investigated the role of CCL2 in physiological and cellular mechanisms of secondary brain damage after TBI. Sustained elevation of CCL2 was detected in the cerebrospinal fluid (CSF) of severe TBI patients for 10 days after trauma, and in cortical homogenates of C57Bl/6 mice, peaking at 4 to 12 h after closed head injury (CHI). Neurological outcome, lesion volume, macrophage/microglia infiltration, astrogliosis, and the cerebral cytokine network were thus examined in CCL2-deficient (−/−) mice subjected to CHI. We found that CCL2−/− mice showed altered production of multiple cytokines acutely (2 to 24 h); however, this did not affect lesion size or cell death within the first week after CHI. In contrast, by 2 and 4 weeks, a delayed reduction in lesion volume, macrophage accumulation, and astrogliosis were observed in the injured cortex and ipsilateral thalamus of CCL2−/− mice, corresponding to improved functional recovery as compared with wild-type mice after CHI. Our findings confirm the significant role of CCL2 in mediating post-traumatic secondary brain damage.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Genetic deletion of CCL2 attenuates lesion volume, reduces macrophage recruitment and astrogliosis, and improves functional outcome compared to controls after CHI.
“Genetic deletion of CC ligand-2 (CCL2), the cognate ligand for CCR2, attenuates lesion volume, reduces macrophage recruitment and astrogliosis, and improves functional outcome compared to controls after CHI (60).”
From The Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease (2018) · cites this paper as [60]
Cited by
Sorted by citations
Neuroinflammation: The Devil Is in the Details
DiSabato, D. J., Quan, N., & Godbout, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13607 · Cited by 1,640 · see citing works
The far-reaching scope of neuroinflammation after traumatic brain injury
Simon, D. W., McGeachy, M. J., Bayır, H., Clark, R. S. B., Loane, D. J., & Kochanek, P. M. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.13 · Cited by 1,190 · see citing works
Inflammation and neuroprotection in traumatic brain injury.
Corps, K. N., Roth, T. L., & McGavern, D. B. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.3558 · Cited by 853 · see citing works
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Jassam, Y. N., Izzy, S., Whalen, M., McGavern, D. B., & El Khoury, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.010 · Cited by 799 · see citing works
Microglia in the TBI brain: The good, the bad, and the dysregulated
Loane, D. J., & Kumar, A. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.08.018 · Cited by 816 · see citing works
“…and its expression is significantly upregulated within hours of head trauma as detected in surgically resected samples and CSF from TBI patients (Semple et al., 2010; Stefini et al., 2008), or in rodent TBI models (Dalgard et al., 2012; Israelsson et al., 2008; Rhodes et al., 2009; Semple et…”
BackgroundTraumatic Brain Injuries: Pathophysiology and Potential Therapeutic Targets
Ng, S. Y., & Lee, A. Y. W. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00528 · Cited by 864 · see citing works
The Role of Markers of Inflammation in Traumatic Brain Injury
Woodcock, T. M., & Morganti-Kossmann, M. C. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00018 · Cited by 719 · see citing works
“In contrast to previous published work, when using the closed brain injury model of focal TBI, we did not find increased expression of TNF in brain homogenates over 24 h (Bye et al., 2007; Semple et al., 2010a).”
BackgroundResultInfluentialSelf-citationBlood–Brain Barrier Pathophysiology in Traumatic Brain Injury
Chodobski, A., Zink, B. J., & Szmydynger‐Chodobska, J. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0125-x · Cited by 655 · see citing works
“Several studies [173, 174, 178, 187] of rodent models of TBI have demonstrated that there is an association between the magnitude of post-traumatic influx of neutrophils and monocytes, and the formation of edema and the extent of brain tissue damage.”
BackgroundBiomarkers of mild traumatic brain injury in cerebrospinal fluid and blood
Zetterberg, H., Smith, D. H., & Blennow, K. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.9 · Cited by 601 · see citing works
Inflammation: the link between comorbidities, genetics, and Alzheimer’s disease
Newcombe, E. A., Camats-Perna, J., Silva, M. L., Valmas, N., Huat, T. J., & Medeiros, R. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1313-3 · Cited by 532 · see citing works
Microglial Activation in Traumatic Brain Injury
Donat, C. K., Scott, G., Gentleman, S., & Sastre, M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00208 · Cited by 489 · see citing works
“…microglia/macrophages: M1: NCD32/CD86 up to 1 dpi M2a/c: NArg-1, CD206, SOCS3, IL-1rn, Gal3 up to 1 dpi, IGF-1 at 5 dpi Pronounced contralateral effects Semple et al., 2010 Mouse CCL2 −/− C57Bl/6 ♂ WD, closed 333 g weight dropped 2 cm, silicone tip hpi: 2, 4, 12, 24 dpi: 4, 7, 14, 28 M1:…”
Zhang, R., Liu, Y., Yan, K., Chen, L., Chen, X.-R., Li, P., Chen, F.-F., & Jiang, X.-D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-106 · Cited by 377 · see citing works
“In the CNS, chemokines secreted by glia and neurons are considered to be essential mediators in the recruitment of leukocytes into damaged parenchyma in post-traumatic neuroinflammation [43].”
BackgroundInfluentialChoroid plexus and the blood–cerebrospinal fluid barrier in disease
Solár, P., Zamani, A., Kubíčková, L., Dubový, P., & Joukal, M. (2020) · Fluids and Barriers of the CNS · doi:10.1186/s12987-020-00196-2 · Cited by 365 · see citing works
Traumatic Brain Injury: Mechanistic Insight on Pathophysiology and Potential Therapeutic Targets
Thapa, K., Khan, H., Singh, T. G., & Kaur, A. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01841-7 · Cited by 341 · see citing works
Gyoneva, S., & Ransohoff, R. M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.003 · Cited by 344 · see citing works
“In the weight-drop model of closed head injury, CCL2 deficiency in mice only slightly affected cell loss and lesion volume in the first 7 dpi, but resulted in reduced lesion size, decreased F4/80 and GFAP immunoreactivity and improved neurological recovery by 28 dpi [42].”
BackgroundCernak, I., Merkle, A., Koliatsos, V., Bilik, J., Luong, Q., Mahota, T. M., Xu, L.-Y., Slack, N., Windle, D., & Ahmed, F. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.10.025 · Cited by 305 · see citing works
Fluid biomarkers for mild traumatic brain injury and related conditions
Zetterberg, H., & Blennow, K. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.127 · Cited by 328 · see citing works
Craniotomy: True Sham for Traumatic Brain Injury, or a Sham of a Sham?
Cole, J. T., Yarnell, A. M., Kean, W. S., Gold, E. M., Lewis, B. K., Ren, M., McMullen, D. C., Jacobowitz, D. M., Pollard, H. B., O’Neill, J. T., et al. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1427 · Cited by 300 · see citing works
Neurogenic inflammation after traumatic brain injury and its potentiation of classical inflammation
Corrigan, F., Mander, K. A., Leonard, A. V., & Vink, R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0738-9 · Cited by 332 · see citing works
“Similarly, within clinical studies, increased levels of IL-6, TNFα, IL-10, C-C motif chemokine ligand 2 (CCL2), and IL-8 peak within the first 2 days following moderate-severe TBI and then return to normal over a period of several weeks [37–39].”
BackgroundCellular infiltration in traumatic brain injury
Alam, A., Thelin, E. P., Tajsic, T., Khan, D. Z., Khellaf, A., Patani, R., & Helmy, A. E. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02005-x · Cited by 298 · see citing works
Morganti, J. M., Jopson, T. D., Liu, S., Riparip, L.-K., Guandique, C. K., Gupta, N., Ferguson, A. R., & Rosi, S. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2405-14.2015 · Cited by 253 · see citing works
“, 2001); and more importantly, CCL2 is significantly elevated in the CSF of human survivors from TBI (Semple et al., 2010).”
BackgroundResultInfluentialInflammation in epileptogenesis after traumatic brain injury
Webster, K. M., Sun, M., Crack, P. J., O'Brien, T. J., Shultz, S. R., & Semple, B. D. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0786-1 · Cited by 273 · see citing works
Self-citationNeuroinflammation in animal models of traumatic brain injury
Chiu, C., Liao, Y.-E., Yang, L.-Y., Wang, J.-Y., Tweedie, D., Karnati, H. K., Greig, N. H., & Wang, J. (2016) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2016.06.018 · Cited by 248 · see citing works
“As described, under pathological conditions in the CNS, chemokines are generated by activated resident local astrocytes and microglia and act to aid recruit peripheral immune cells into the brain parenchyma (Das et al., 2012; Semple et al., 2010b; Ziebell and Morganti-Kossmann, 2010).”
BackgroundHammond, M. D., Taylor, R. A., Mullen, M. T., Ai, Y., Aguila, H. L., Mack, M., Kasner, S. E., McCullough, L. D., & Sansing, L. H. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4070-13.2014 · Cited by 226 · see citing works
“However, others have shown that these cells initiate secondary injury in models of ischemic stroke, myocardial infarction, and traumatic brain injury (Dimitrijevic et al., 2007; Semple et al., 2010; Leuschner et al., 2011).”
BackgroundPriming the Inflammatory Pump of the CNS after Traumatic Brain Injury
Witcher, K. G., Eiferman, D. S., & Godbout, J. P. (2015) · Trends in Neurosciences · doi:10.1016/j.tins.2015.08.002 · Cited by 222 · see citing works
Kumar, A., Barrett, J. P., Alvarez-Croda, D.-M., Stoica, B. A., Faden, A. I., & Loane, D. J. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.07.158 · Cited by 213 · see citing works
“…macrophage infiltration and improves long-term neurological recovery after TBI (Hsieh et al., 2014; Israelsson et al., 2014; Morganti et al., 2015; Semple et al., 2010), indicating that the accumulation of macrophages in the TBI brain contributes to post-traumatic neuroinflammation and secondary…”
InfluentialXu, X.-E., Liu, L., Wang, Y.-C., Wang, C.-T., Zheng, Q., Liu, Q.-X., Li, Z.-F., Bai, X.-J., & Liu, X.-H. (2019) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.05.038 · Cited by 211 · see citing works
Cytokines and innate inflammation in the pathogenesis of human traumatic brain injury.
Helmy, A., Simoni, M. D., Guilfoyle, M., Carpenter, K., & Hutchinson, P. (2011) · Progress in neurobiology · doi:10.1016/j.pneurobio.2011.09.003 · Cited by 208 · see citing works
Morganti-Kossmann, M. C., Semple, B. D., Hellewell, S. C., Bye, N., & Ziebell, J. M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1944-6 · Cited by 221 · see citing works
Self-citationZiebell, J. M., Taylor, S. E., Cao, T., Harrison, J., & Lifshitz, J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-247 · Cited by 185 · see citing works
“In focal TBI, active and amoeboid microglia are found throughout the contused or cavitated tissue and thought to promote tissue degeneration and contribute to repair [8,11,13-15,27,34].”
Self-citationKalra, S., Malik, R., Singh, G., Bhatia, S., Al‐Harrasi, A., Mohan, S., Albratty, M., Albarrati, A., & Tambuwala, M. M. (2022) · Inflammopharmacology · doi:10.1007/s10787-022-01017-8 · Cited by 202 · see citing works
The Choroid Plexus in Healthy and Diseased Brain
Kaur, C., Rathnasamy, G., & Ling, E.-A. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlv030 · Cited by 176 · see citing works
“It is well documented that MCP-1, also known as CCL2, drives the influx of inflammatory cells in the brain tissue in traumatic conditions (173, 174).”
BackgroundHsieh, C. L., Niemi, E. C., Wang, S. H., Lee, C. C., Bingham, D., Zhang, J., Cozen, M. L., Charo, I., Huang, E. J., Liu, J., et al. (2014) · Journal of Neurotrauma · doi:10.1089/neu.2013.3252 · Cited by 174 · see citing works
Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat
Cao, T., Thomas, T. C., Ziebell, J. M., Pauly, J. R., & Lifshitz, J. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.08.058 · Cited by 160 · see citing works
Self-citationTraumatic brain injury induces macrophage subsets in the brain
Hsieh, C. L., Kim, C. C., Ryba, B. E., Niemi, E. C., Bando, J. K., Locksley, R. M., Liu, J., Nakamura, M. C., & Seaman, W. E. (2013) · European Journal of Immunology · doi:10.1002/eji.201243084 · Cited by 179 · see citing works
“Using YARG and Yet40 reporter mice, we did not detect arginase-1, IL12p40, or MHCII expression in microglia before or after TBI.”
BackgroundInfluentialPatel, N. A., Moss, L. D., Lee, J.-Y., Tajiri, N., Acosta, S., Hudson, C., Parag, S., Cooper, D. R., Borlongan, C. V., & Bickford, P. C. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1240-3 · Cited by 175 · see citing works
Cell‐specific blood–brain barrier regulation in health and disease: a focus on hypoxia
Engelhardt, S., Patkar, S., & Ogunshola, O. O. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12489 · Cited by 165 · see citing works
“reported its important role in reducing lesion size and secondary damage and improving functional outcome in mice following TBI (Semple et al., 2010).”
BackgroundDoran, S. J., Ritzel, R., Glaser, E. P., Henry, R., Faden, A., & Loane, D. (2019) · Journal of Neurotrauma · doi:10.1089/neu.2018.6019 · Cited by 154 · see citing works
Dissemination of brain inflammation in traumatic brain injury
Shi, K., Zhang, J., Dong, J., & Shi, F. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0213-5 · Cited by 181 · see citing works
Brain trauma elicits non-canonical macrophage activation states
Kim, C. C., Nakamura, M. C., & Hsieh, C. L. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0581-z · Cited by 149 · see citing works
“In fact, studies have identified Ccr2 as a potential target to improve the functional outcomes of TBI [5, 7, 21, 31].”
BackgroundClausen, F., Hånell, A., Israelsson, C., Hedin, J., Ebendal, T., Mir, A. K., Gram, H., & Marklund, N. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07723.x · Cited by 148 · see citing works
“In contrast, invading Ccr2-expressing monocytes may be detrimental to the injured brain (Semple et al., 2010).”
BackgroundRod Microglia: A Morphological Definition
Taylor, S. E., Morganti-Kossmann, M. C., Lifshitz, J., & Ziebell, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097096 · Cited by 138 · see citing works
Self-citationMuccigrosso, M. M., Ford, J., Benner, B., Moussa, D., Burnsides, C., Fenn, A. M., Popovich, P. G., Lifshitz, J., Walker, F. R., Eiferman, D. S., et al. (2016) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.01.009 · Cited by 146 · see citing works
Hellewell, S., Yan, E., Agyapomaa, D., Bye, N., & Morganti-Kossmann, M. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1245 · Cited by 138 · see citing works
“…have been shown to accumulate in both focal and diffuse TBI, beginning at 24h and peaking between 3 and 7 days after injury (Aihara et al., 1995; Bye et al., 2007; Csuka et al., 2000; Hausmann et al., 1999; Kelley et al., 2007; Oehmichen et al., 1999; Semple et al., 2010; Williams et al., 2007).”
InfluentialSelf-citationThe cytokine temporal profile in rat cortex after controlled cortical impact
Dalgard, C., Cole, J., Kean, W., Lucky, J. J., Sukumar, G., McMullen, D., Pollard, H., & Watson, W. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00006 · Cited by 136 · see citing works
“This observation supports previous information that CCL2 is routinely measurable in brain tissue (Glabinski et al., 1996) and cerebrospinal fluid (Semple et al., 2010a) due to both high basal concentrations and to sensitivity to injury (Muessel et al., 2000; Rancan et al., 2001).”
BackgroundResultInfluentialInflammatory monocytes and the pathogenesis of viral encephalitis
Terry, R. L., Getts, D. R., Deffrasnes, C., van Vreden, C., Campbell, I. L., & King, N. J. C. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-270 · Cited by 134 · see citing works
“mice showed reductions in macrophage infiltration and lesion volume compared to wild-type mice, corresponding with improved functional recovery after injury [159].”
BackgroundDang, J., Mitkari, B., Kipp, M., & Beyer, C. (2011) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2011.01.013 · Cited by 130 · see citing works
“Levels of VEGF, CCL2 and CCL5 within the penumbra region were quantified by commercially available ELISA kits according to the manufacturer’s instructions (all Peprotech, Germany).”
BackgroundInfluentialPosttraumatic Invasion of Monocytes across the Blood—Cerebrospinal Fluid Barrier
Szmydynger-Chodobska, J., Strazielle, N., Gandy, J., Keefe, T. H., Zink, B., Ghersi-Egea, J., & Chodobski, A. (2012) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/jcbfm.2011.111 · Cited by 129 · see citing works
“The influx of these inflammatory cells is driven by monocyte chemoattractants, such as CCL2, whose synthesis is rapidly increased in the injured cortex (Semple et al, 2010a; Szmydynger-Chodobska et al, 2010).”
BackgroundResultInfluentialThe Inflammatory Continuum of Traumatic Brain Injury and Alzheimer’s Disease
Kokiko-Cochran, O. N., & Godbout, J. P. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00672 · Cited by 128 · see citing works
“Singleincident mild CHI TBI in aged hTau transgenic mice that express all six isoforms of hTau in absence of murine tau did not worsen 8 Kokiko-Cochran and Godbout Inflammatory Continuum of Brain Injury Frontiers in Immunology | www.frontiersin.org April 2018 | Volume 9 | Article 672 tau phosphorylation or induce tau…”
BackgroundInfluentialThe current state of biomarkers of mild traumatic brain injury
Kim, H., Tsao, J. W., & Stanfill, A. G. (2018) · JCI Insight · doi:10.1172/jci.insight.97105 · Cited by 127 · see citing works
Su, Y., Fan, W., Ma, Z., Wen, X., Wang, W., Wu, Q., & Huang, H. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.02.006 · Cited by 124 · see citing works
“The potential role of MCP-1 was investigated in MCP-1 knockout mice, suggesting that MCP-1 plays an important role in secondary brain damage (Semple et al., 2010).”
Harrison, J. L., Rowe, R. K., Ellis, T. W., Yee, N., O’Hara, B. F., Adelson, P. D., & Lifshitz, J. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.001 · Cited by 117 · see citing works
Battista, A. P. D., Buonora, J., Rhind, S., Hutchison, M., Baker, A., Rizoli, S., Diaz-Arrastia, R., & Mueller, G. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00110 · Cited by 116 · see citing works
Semple, B. D., Bye, N., Ziebell, J. M., & Morganti-Kossmann, M. C. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.015 · Cited by 113 · see citing works
“In the current investigation using mice on a Balb/C background, we found less errors on the ledged beam test overall compared to C57Bl/6micewith a similar injury severity (Bye et al., 2007; Semple et al., 2010a), making any potential differences between strains less likely to be detected.”
InfluentialSelf-citationSharma, R., Shultz, S. R., Robinson, M. J., Belli, A., Hibbs, M. L., O'Brien, T. J., & Semple, B. D. (2019) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2019.04.034 · Cited by 137 · see citing works
Self-citationYan, E., Hellewell, S., Bellander, B., Agyapomaa, D., & Morganti-Kossmann, M. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-147 · Cited by 108 · see citing works
“The concentration of 6 cytokines (IL-1b, IL-2, IL-4, IL-6, IL-10, TNF) in the brain cortex homogenates was determined by multiplex assay as previously used in our group [57] (Bio-Rad Laboratories, Hercules, CA, USA).”
MethodSelf-citationNeuroinflammation Following Traumatic Brain Injury: Take It Seriously or Not
Zheng, R.-Z., Lee, K., Qi, Z.-X., Wang, Z., Xu, Z.-Y., Wu, X., & Mao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.855701 · Cited by 106 · see citing works
“The contribution of infiltrated neutrophils to TBI pathogenesis varies as follows: 1) neutrophil depletion can reduce edema and microglial activation (87); 2) similar results can be obtained in the CCL2 genetic deficient model (88), and 3) the neutrophil extracellular traps (NETs) can improve neurological function (89…”
BackgroundCranial Irradiation Alters the Brain’s Microenvironment and Permits CCR2+ Macrophage Infiltration
Morganti, J. M., Jopson, T. D., Liu, S., Gupta, N. M., & Rosi, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093650 · Cited by 101 · see citing works
Inflammation in Traumatic Brain Injury
Postolache, T. T., Wadhawan, A., Can, A., Lowry, C. A., Woodbury, M., Makkar, H., Hoisington, A. J., Scott, A. J., Potocki, E., Benros, M. E., et al. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-191150 · Cited by 150 · see citing works
“The chemokine CCL2 signals the deployment of monocytes [158, 159] after TBI and elicits CCR2 + monocyte recruitment.”
Principal Component Analysis of the Cytokine and Chemokine Response to Human Traumatic Brain Injury
Helmy, A. E., Antoniades, C. A., Guilfoyle, M. R., Carpenter, K. L. H., & Hutchinson, P. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039677 · Cited by 103 · see citing works
Chen, C.-C., Hung, T.-H., Lee, C.-Y., Wang, L., Wu, C.-H., Ke, C.-H., & Chen, S.-F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115694 · Cited by 101 · see citing works
Acute drivers of neuroinflammation in traumatic brain injury
Wofford, K. L., Loane, D. J., & Cullen, D. K. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.255958 · Cited by 103 · see citing works
“While these data cannot be overlooked, contradictory results in the field of neuroinflammation could also suggest that peripheral macrophages play an important role in tissue preservation and regeneration (Semple et al., 2010).”
InfluentialCSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics
Jeppsson, A., Wikkelsø, C., Blennow, K., Zetterberg, H., Constantinescu, R., Remes, A. M., Herukka, S., Rauramaa, T. H., Nägga, K., Leinonen, V., et al. (2019) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-320826 · Cited by 95 · see citing works
Ahmed, N., Murakami, M., Hirose, Y., & Nakashima, M. (2016) · Stem Cells International · doi:10.1155/2016/8102478 · Cited by 96 · see citing works
“While VEGF secretion enhances angiogenesis during tissue repair [22], RANTES was found to increase neuronal cell survival and to have a neuroprotective effect [20], and FRACTALKINE is considered as a key microglial pathway in protecting against AD-related cognitive deficits [23].”
InfluentialCcr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury
Gyoneva, S., Kim, D., Katsumoto, A., Kokiko-Cochran, O. N., Lamb, B. T., & Ransohoff, R. M. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0443-0 · Cited by 95 · see citing works
“Deletion of Ccl2, a ligand for CCR2, Ccr2 itself or antagonism of CCR2 with small molecules have all been shown to be beneficial after TBI [23, 30, 45–47].”
BackgroundCollins-Praino, L. E., & Corrigan, F. (2017) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2016.09.027 · Cited by 95 · see citing works
“…levels of cytokines and chemokines within the CSF following moderate-severe TBI found increased levels of IL-6, TNFa, IL-10, CCL2 and IL-8 which peak within the first 24–48 h after TBI and then decrease over several weeks (MorgantiKossman et al., 1997; Csuka et al., 1999; Semple et al., 2010).”
BackgroundHill, R., Zhang, Y.-P., Burke, D., Devries, W. H., Zhang, Y.-J., Magnuson, D., Whittemore, S., & Shields, C. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0543 · Cited by 93 · see citing works
Neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets
Sharma, R., Leung, W. L., Zamani, A., O'Brien, T. J., Casillas-Espinosa, P. M., & Semple, B. D. (2019) · Brain Sciences · doi:10.3390/brainsci9110318 · Cited by 102 · see citing works
“CCL2 Release by infiltrated macrophages further promotes peripheral macrophage infiltration [48] Absence of CCL2 results in delayed secretion of different pro-inflammatory cytokines [99,100] Pro-ictogenic [101–104] (experimental evidence)”
BackgroundSelf-citationMakinde, H., Cuda, C., Just, T. B., Perlman, H., & Schwulst, S. J. (2017) · Journal of Immunology · doi:10.4049/jimmunol.1700896 · Cited by 89 · see citing works
“understanding of the role of these individual monocytic subtypes in TBI is rapidly evolving (16, 21, 22).”
BackgroundTherapies negating neuroinflammation after brain trauma
Hellewell, S. C., Semple, B. D., & Morganti-Kossmann, M. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.12.024 · Cited by 92 · see citing works
Self-citationCCL2 is associated with microglia and macrophage recruitment in chronic traumatic encephalopathy
Cherry, J. D., Meng, G., Daley, S. A., Xia, W., Svirsky, S. E., Alvarez, V. E., Nicks, R., Pothast, M. J., Kelley, H. J., Huber, B. R., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02036-4 · Cited by 108 · see citing works
“This comparison provides compelling evidence that glial recruitment signals are directed to the regions of greatest injury and CTE pathology as opposed to a non-specific TBI-related brain-wide increase.”
BackgroundInfluentialHelmy, A., Guilfoyle, M., Carpenter, K., Pickard, J., Menon, D., & Hutchinson, P. (2016) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1177/0271678x15620204 · Cited by 86 · see citing works
Welch, G. M., Boix, C. A., Schmauch, E., Davila-Velderrain, J., Victor, M. B., Dileep, V., Bozzelli, P. L., Su, Q., Cheng, J. D., Lee, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo4662 · Cited by 84 · see citing works
Traumatic brain injury enhances neuroinflammation and lesion volume in caveolin deficient mice
Niesman, I., Schilling, J., Shapiro, L. A., Kellerhals, S., Bonds, J. A., Kleschevnikov, A., Cui, W.-H., Voong, A., Krajewski, S., Ali, S., et al. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-39 · Cited by 84 · see citing works
“Persistently elevated expression of MCP-1 in both Cav KO mice indicates a disruption in the normal signaling and trafficking of the MCP-1/CCR2 (MCP-1 receptor) complex, an interesting finding considering that previous work showed that MCP-1 KO mice have attenuated lesion size and less astrogliosis following TBI [49].”
ResultDiffuse Brain Injury Induces Acute Post-Traumatic Sleep
Rowe, R. K., Striz, M., Bachstetter, A., Eldik, L. V. V., Donohue, K., O'Hara, B., & Lifshitz, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082507 · Cited by 84 · see citing works
Gao, C., Qian, Y., Huang, J., Wang, D., Su, W., Wang, P., Guo, L., Quan, W., An, S., Zhang, J.-N., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0318-0 · Cited by 82 · see citing works
Semple, B. D., Trivedi, A. A., Gimlin, K., & Noble‐Haeusslein, L. J. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.003 · Cited by 90 · see citing works
“Neutrophil depletion (Kenne et al., 2012), as well as strategies to reduce neutrophil adhesion and infiltration (Knoblach and Faden, 2002; Semple et al., 2010a; Bao et al., 2012), affords varying degrees of neuroprotection in adult models of TBI, providing evidence of a biologically significant…”
BackgroundSelf-citationRong, Y., Ji, C., Wang, Z., Ge, X., Wang, J., Wu, Y., Tang, P., Jiang, D., Fan, J., Yin, G., et al. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02268-y · Cited by 96 · see citing works
“Previous studies have shown that mice lacking CCL2 exhibit delayed cell death, decreased microglial activation, altered expression of cell death molecules, and improved neurological recovery after CNS injury [9, 10].”
BackgroundUnderstanding Immune‐Driven Brain Aging by Human Brain Organoid Microphysiological Analysis Platform
Ao, Z., Song, S., Tian, C., Cai, H., Li, X., Miao, Y., Wu, Z., Krzesniak, J., Ning, B., Gu, M., et al. (2022) · Advanced Science · doi:10.1002/advs.202200475 · Cited by 77 · see citing works
Management of Traumatic Brain Injury: From Present to Future
Crupi, R., Cordaro, M., Cuzzocrea, S., & Impellizzeri, D. (2020) · Antioxidants · doi:10.3390/antiox9040297 · Cited by 77 · see citing works
“IL-6, IL-8, IL-10 Neuroinflammation Animal and clinical models of TBI [39,40] MMP mTBI patients [41] MBG [42]”
BackgroundSun, M., Brady, R. D., Wright, D. K., Kim, H. A., Zhang, S. R., Sobey, C. G., Johnstone, M. R., O'Brien, T. J., Semple, B. D., McDonald, S. J., et al. (2017) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2017.08.005 · Cited by 79 · see citing works
Self-citationTruettner, J. S., Bramlett, H., & Dietrich, W. (2017) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1177/0271678x16680003 · Cited by 75 · see citing works
Elevated expression of MCP-1, IL-2 and PTPR-N in basal ganglia of Tourette syndrome cases.
Morer, A., Chae, W., Henegariu, O., Bothwell, A., Leckman, J., & Kawikova, I. (2010) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2010.02.007 · Cited by 75 · see citing works
Role of Toll-like receptor mediated signaling in traumatic brain injury
Shi, H., Hua, X., Kong, D., Stein, D. G., & Hua, F. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.07.022 · Cited by 86 · see citing works
Sawada, A., Niiyama, Y., Ataka, K., Nagaishi, K., Yamakage, M., & Fujimiya, M. (2014) · Pain · doi:10.1016/j.pain.2014.05.031 · Cited by 86 · see citing works
“MCP-1 is a member of the CC family of chemokines that specifically attracts and activates macrophages to damaged parenchyma after traumatic brain injury [3,31].”
BackgroundKnockout of ccr2 alleviates photoreceptor cell death in a model of retinitis pigmentosa
Guo, C., Otani, A., Oishi, A., Kojima, H., Makiyama, Y., Nakagawa, S., & Yoshimura, N. (2012) · Experimental Eye Research · doi:10.1016/j.exer.2012.08.013 · Cited by 81 · see citing works
“…CNS diseases (Conductier et al., 2010; Gerard and Rollins, 2001) such as autoimmune encephalomyelitis (Fife et al., 2000; Huang et al., 2001; Izikson et al., 2000), Alzheimer disease (Hickman and El Khoury, 2010), ischemic neuropathy (Kim et al., 2005), and trauma (Semple et al., 2010).”
BackgroundCCL2 modulates cytokine production in cultured mouse astrocytes
Semple, B., Frugier, T., & Morganti-Kossmann, M. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-67 · Cited by 72 · see citing works
“Detection of elevated CCL2 in the serum and cerebrospinal fluid of severe TBI patients [9,10] corroborates a central role for this chemokine in post-traumatic neuroinflammation.”
BackgroundResultInfluentialSelf-citationRhodes, J., Sharkey, J., & Andrews, P. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0686 · Cited by 72 · see citing works
Fang, J., Yuan, Q., Du, Z., Zhang, Q., Yang, L., Wang, M., Yang, W., Yuan, C., Yu, J., Wu, G., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.04.014 · Cited by 71 · see citing works
Gu, C., Geng, X., Wu, Y., Dai, Y., Zeng, J., Wang, Z., Fang, H.-P., Sun, Y.-Q., & Chen, X.-S. (2023) · Small · doi:10.1002/smll.202305659 · Cited by 69 · see citing works
Does C-C Motif Chemokine Ligand 2 (CCL2) Link Obesity to a Pro-Inflammatory State?
Dommel, S., & Blüher, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031500 · Cited by 81 · see citing works
“Indeed, CCL2 expression in glial cells is increased in epilepsy, brain ischemia, Alzheimer’s disease, and traumatic brain injury [161,162].”
BackgroundChou, A., Krukowski, K., Morganti, J. M., Riparip, L., & Rosi, S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061616 · Cited by 78 · see citing works
Orio, L., Antón, M., Rodríguez-Rojo, I. C., Correas, Á., García-Bueno, B., Corral, M., de Fonseca, F. D., García-Moreno, L., Maestú, F., & Cadaveira, F. (2018) · Addiction Biology · doi:10.1111/adb.12543 · Cited by 67 · see citing works
“MCP-1 deficiency in experimental brain injury models decreases macrophage accumulation, neural loss and astrocyte accumulation, resulting in improvements in neurological outcomes (Semple et al. 2010).”
BackgroundGagnidze, K., Hajdarovic, K. H., Moskalenko, M., Karatsoreos, I., McEwen, B., & Bulloch, K. (2016) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.1520489113 · Cited by 67 · see citing works
Hebron, M., Lonskaya, I., Olopade, P., Selby, S., Pagán, F., & Moussa, C. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000259 · Cited by 67 · see citing works
“CCL2 is expressed by neurons throughout the brain [71] and its expression level in glial cells is increased in epilepsy [72,73], brain ischemia [74], AD [75], experimental autoimmune encephalomyelitis (EAE) [76], and traumatic brain injury (TBI) [77].”
BackgroundCCR2 deficiency alters activation of microglia subsets in traumatic brain injury
Somebang, K., Rudolph, J. D., Imhof, I., Li, L., Niemi, E. C., Shigenaga, J. K., Tran, H., Gill, T. M., Lo, I., Zabel, B. A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109727 · Cited by 74 · see citing works
Tobin, R., Mukherjee, S., Kain, J., Rogers, S., Henderson, S. K., Motal, H. L., Rogers, M. K. N., & Shapiro, L. A. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0143-5 · Cited by 64 · see citing works
“While CCL2 is a well-described marker of inflammation after TBI [57,58], and CAP reduced its expression in this study, less understood is the putative roles of IL15, IL13 and IL10, that were also reduced by CAP.”
BackgroundNg, S. Y., Semple, B. D., Morganti-Kossmann, M. C., & Bye, N. (2012) · Journal of Neurotrauma · doi:10.1089/neu.2011.2188 · Cited by 55 · see citing works
“We and others have extensively characterized post-traumatic cerebral inflammation in a focal closed head injury (CHI) model, and we have recently demonstrated that a robust microglial response occurs in the injured cortex, peaking from 4–7 days after injury (Bye et al., 2007; Semple et al., 2010; Ziebell et al., 2011).”
InfluentialSelf-citationRowe, R. K., Harrison, J., O'Hara, B., & Lifshitz, J. (2014) · Sleep · doi:10.5665/sleep.3582 · Cited by 62 · see citing works
CNS inflammation and bone marrow neuropathy in type 1 diabetes.
Hu, P., Thinschmidt, J., Yan, Y., Hazra, S., Bhatwadekar, A., Caballero, S., Salazar, T. E., Miyan, J., Li, W.-C., Derbenev, A., et al. (2013) · American Journal of Pathology · doi:10.1016/j.ajpath.2013.07.009 · Cited by 62 · see citing works
- Authors
- Semple, B. D., Bye, N., Rancan, M., Ziebell, J. M., & Morganti-Kossmann, M. C.
- Affiliations
- The Alfred Hospital (AU)
- Triemli Hospital (CH)
- Corresponding author
- Morganti-Kossmann, M Cristina
- Venue
- Journal of Cerebral Blood Flow & Metabolism
- Publisher
- SAGE Publications
- Published
- 2009-12-23
- Volume
- 30
- Issue
- 4
- Pages
- 769-782
- ISSN
- 0271-678X (ISSN-L)
- 1559-7016
- PMC
- PMC2949175
- OpenAlex
- W2159744238
- Cited by
- 358
- References
- 0
- Citations by year
- 2026: 8 · 2025: 21 · 2024: 24 · 2023: 17 · 2022: 29 · 2021: 20 · 2020: 25 · 2019: 18 · 2018: 25 · 2017: 20 · 2016: 29 · 2015: 25 · 2014: 27 · 2013: 23 · 2012: 23
- FWCI
- 10.00
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Cerebral Blood Flow & Metabolism (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eCite Digital Repository (University of Tasmania) (submittedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Figshare (submittedVersion)
- Funders
- Universitätsspital Zürich
- Topics
- Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Automotive and Human Injury Biomechanics
- Keywords
- MCP-1, traumatic brain injury, chemokines, secondary brain injury, macrophage recruitment, microglia, astrocyte activation, cerebrospinal fluid biomarkers, closed head injury, neuroinflammation, lesion volume, functional recovery, cytokines
- MeSH terms
- Animals, Brain, Brain Injuries, Gliosis, Humans, Inflammation, Macrophages, Mice, Inbred C57BL, Biomarkers, Cytokines, Mice, Knockout, Chemokine CCL2, In Situ Nick-End Labeling, Mice, Receptors, CCR2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review